Positive treatment response improves the health-ralated quality of life of patients with early rheumatiod arthritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 1, 2009, Pages 108-111

  Uutela, Toini ^a   Hannonen, P ^b   Kautianen, H ^c   Hakala, M ^c,d   Paananen, M L ^b   Hakkinen A ^b,e  

^a LAPLAND CENTRAL HOSPITAL   (Finland)

^b Central Hospital of Juväskylä   (Finland)

^c RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

Outcome; Quality of life; Rheumatoid arthritis; Treatment response

Indexed keywords

PREDNISOLONE; SALAZOSULFAPYRIDINE;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; EMOTION; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT MOBILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SLEEP; SOCIAL ISOLATION; TREATMENT RESPONSE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 63049090337     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. NICHOL MB, HARADA ASM: Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. Pharmacoeconomics 1999; 16: 433-48.
2. POLLARD L, CHOY EH, SCOTT DL: The consequences of rheumatoid arthritis: Quality of life measures in the individual patient. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S43-S52.
3. SCOTT DL, SMITH C, KINGSLEY G: What are the consequences of early rheumatoid arthritis for the individual? Best Pract Res Cl Rh 2005; 19: 117-36.
4. SHARPE L, SENSKY T, BREWIN CR, ALLARD S: Characteristics of handicap for patients with recent onset rheumatoid arthritis: The validity of the Disease Repercussion Profile. Rheumatology 2001; 40: 1169-74.
5. FRIES JE, SPITZ P, KRAINES RG, HOLMAN HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
6. BRUCE B, FRIES JF: The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005; 23 (Suppl. 39): S14-S18.
7. WARE JE, SHERBOURNE CD: The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 1992; 30: 473-83.
8. HUNT SM, MCEWEN J, MCKENNA SP: Measuring health status. London: Croom Helm, 1986.
9. KIRWAN JR, HEWLETT SE, HEIBERG T et al.: OMERACT 7 Workshop. Incorporating the patients perspective into outcome assessment in rheumatoid arthritis - progress at OMERACT 7. J Rheumatol 2005; 32: 2250-6.
10. KOSINSKI M, KUJAWSKI SC, MARTIN R et al.: Health-related Quality of Life in early rheumatoid arthritis: Impact of disease and treatment response. Am J Manag Care 2002; 8: 231-40.
11. SMEDSTAD LM, VAGLUM P, KVIEN T, MOUM T: The relationship between self-reported pain and sociodemographic variables, anxiety, and depressive symptoms in rheumatoid arthritis. J Rheumatol 1995; 22: 514-20.
12. SUURMEIER THPBM, WALTZ M, MOUM T et al.: Quality of life profiles in the first years of rheumatoid arthritis: Results from the EURIDISS longitudinal study. Arthritis Care Res 2001; 45: 111-21.
13. KROL B, SANDERMAN R, SUURMEIER T, DOEGLAS D, VAN RIJSWIJK M, LEEUWEN M: Medical, physical and psychological status related to early rheumatoid arthritis. Clin Rheumatol 1995; 14: 143-50.
14. EULAR response criteria available from http://www.das-score.n1/ www.das-score,n1/how_to_use2.html (Ref. on Aug. 12, 2007).
15. ARNETT FC, EDwbRTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
16. KOIVUKANGAS P, OHINMAA A, KOIVUKANGAS J: The Finnish version of the Nottingham Health Profile/English summary. Research reports 187, STAKES, Saarijärvi, 1995.
17. SCOTT DL, GARROOD T:UQuality of life measures: use and abuse. Bailliers Best Pract Res Clin Rheumatol 2000; 14: 663-87.
18. PREVOO MLL, VAN'T HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LBA, VAN RIEL LCM: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 1: 44-8.
19. LARSEN A, DALE K, EEK M: Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol (Diagn) (Stockh) 1977; 18: 481-91.
20. HAKALA M, NIEMINEN P, MANELIUS J: Joint impairment is strongly correlated with disability measured by self-reported questionnaires. Functional status assessment of individuals with rheumatoid arthritis in a population based series. J Rheumatol 1994; 21: 64-9.
21. MITTLEMAN BB, LIPSKYAP: Patient-centred outcomes: a bridge too far? Nat Clin Pract Rheumatol 2006; 2 (Editorial): 457.
22. RUSSAK SM, CROFT JD, FURST DE et al.: On behalf of the EVIDENCE-BASED MEDICINE WORKING GROUPS IN RHEUMATOLOGY. The use of rheumatoid arthritis Health-Related Quality of Life Patient Questionnaires in clinical practice: Lesson learned. Arthritis Rheum 2003; 49: 574-84.
23. HEIBERG T, KVIEN TK: Preferences for Improved health examined in 1.024 patients with rheumatoid arthritis: Pain has highest priority. Arthritis Rheum 2002; 47: 391-7.
24. HEWLETT S, COCKSHOTT Z, BYRON M et al.: Patients' perceptions of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored. Arthritis Rheum 2005; 53: 697-702.
25. PINALS RS, MASI AT, LARSEN RA: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308-15.
26. WOLFE F, HAWLEY DJ, WILSON K: The prevalence and meaning of fatigue in rheumatoid disease. J Rheumatol 1996; 23: 1407-17.
27. HUYSER BA, PARKER JC, THORESON R, SMARR KL, JOHNSON JC, HOFFMAN R: Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum 1998; 41: 2230-7.
28. WEINBLATT ME, KEYSTONE EC, FURST DE et al.: Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate. The ARMADA Trial. Arthritis Rheum 2003; 48: 35-45.
29. MORELAND LW, GENOVESE MC, SATO R, SINGH A: Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis. Arthritis Rheum 2006; 55: 287-93.
30. ZAUTRA AJ, BURLESON MH, BLALOCK SJ et al.: Arthritis and perceptions of quality of life: An examination of positive and negative affect in rheumatoid arthritis patients. Health Psychol 1995; 14: 399-408.
31. MCHORNEY CA, TARLOW AR: Individual-patient monitoring in clinical practice: Are available health status surveys adequate? Qual Life Res 1995; 4: 293-307.